Karo Pharma AB (publ)

Informe acción OM:KARO

Capitalización de mercado: kr16.6b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Karo Pharma Dirección

Dirección controles de criterios 1/4

Información clave

Christoffer Lorenzen

Chief Executive Officer (CEO)

kr12.6m

Compensación total

Porcentaje del salario del CEO35.8%
Permanencia del CEO3.3yrs
Participación del CEOn/a
Permanencia media de la dirección2.2yrs
Promedio de permanencia en la Junta Directiva2.5yrs

Actualizaciones recientes de la dirección

Recent updates

Karo Pharma (STO:KARO) Has No Shortage Of Debt

Oct 14
Karo Pharma (STO:KARO) Has No Shortage Of Debt

Is Karo Pharma (STO:KARO) A Risky Investment?

Jul 10
Is Karo Pharma (STO:KARO) A Risky Investment?

Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt

Mar 23
Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt

Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality

Feb 24
Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality

Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?

Feb 22
Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?

Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?

Feb 01
Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Christoffer Lorenzen en comparación con los beneficios de Karo Pharma?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2022n/an/a

-kr190m

Mar 31 2022n/an/a

-kr141m

Dec 31 2021kr13mkr5m

-kr17m

Sep 30 2021n/an/a

kr63m

Jun 30 2021n/an/a

kr2m

Mar 31 2021n/an/a

kr49m

Dec 31 2020kr12mkr5m

kr82m

Sep 30 2020n/an/a

kr86m

Jun 30 2020n/an/a

kr87m

Mar 31 2020n/an/a

kr55m

Dec 31 2019kr16mkr2m

kr9m

Compensación vs. Mercado: Christoffer's total compensation ($USD1.20M) is above average for companies of similar size in the Swedish market ($USD901.38K).

Compensación vs. Ingresos: Christoffer's compensation has increased whilst the company is unprofitable.

CEO

Christoffer Lorenzen (47 yo)

3.3yrs

Permanencia

kr12,564,000

Compensación

Mr. Christoffer Lorenzen has been the Chief Executive Officer of Karo Pharma AB since July 1, 2019. Mr. Lorenzen was an Executive Vice President of Food Cultures & Enzymes at Chr. Hansen Holding A/S from A...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Christoffer Lorenzen
Chief Executive Officer3.3yrskr12.56msin datos
Jon Johnsson
Chief Financial Officer3.1yrssin datossin datos
Jonathan Kimber
Vice President of Operations3.2yrssin datossin datos
Sofia Kyhlstedt
Vice President of Scientific Affairsno datasin datossin datos
Lisa Westerdahl
VP of Commercial Pharma Operations & Corporate Communicationsno datasin datossin datos
Anna Hale
Chief Marketing Officer1.8yrssin datossin datos
Karin Lindberg
Head of People & Organization2.5yrssin datossin datos
SIMON Nyberg-Hansen
Managing Director of Norwayno datasin datossin datos
Fredrik Thorsen
Head of Digital & E-commerce1.5yrssin datossin datos
Matt Roberts
Chief Commercial Officer1.2yrssin datossin datos
Robin List
Chief Executive Officer of Sylpharless than a yearsin datossin datos
Anna Elmblad
Vice President of Digital Marketingno datasin datossin datos

2.2yrs

Permanencia media

47yo

Promedio de edad

Equipo directivo experimentado: KARO's management team is considered experienced (2.2 years average tenure).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Mark Keatley
Independent Director1.6yrskr413.00ksin datos
Uta Kemmerich-Keil
Independent Director2.5yrskr394.00ksin datos
Erika Henriksson
Director3.8yrskr394.00ksin datos
Flemming Ørnskov
Independent Director3.1yrskr394.00ksin datos
Kristofer Tonström
Independent Director2.5yrskr394.00ksin datos
Patrick Smallcombe
Independent Chairman1.6yrskr552.00ksin datos
Claire Hennah
Independent Directorless than a yearsin datossin datos

2.5yrs

Permanencia media

56yo

Promedio de edad

Junta con experiencia: KARO's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.